AlphaYouRH
Insider selling
Robert Hershberg sold $125K of Recursion Pharmaceuticals, Inc. (RXRX) stock
Robert Hershberg, Dir of Recursion Pharmaceuticals, Inc. (RXRX), sold 25,000 shares of RXRX stock worth $125K, per an SEC Form 4 filed Oct 7, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade happened on Oct 6, 2026, 1 day before it was made public.
RXRX has moved -7.8% since the trade date, from $4.63 to $4.27 (Oct 7, 2026 close).
- Traded
- Oct 6, 2026
- Disclosed
- Oct 7, 2026
- Filing delay
- 1 day
- Price since
- -7.8%
- Role
- Dir
- Source
- SEC Form 4
More RXRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.